Agency Forms Undergoing Paperwork Reduction Act Review, 2508-2509 [2019-01327]
Download as PDF
<![CDATA[
2508
Federal Register / Vol. 84, No. 26 / Thursday, February 7, 2019 / Notices
implement regulations relating to the
open market operations conducted by
Federal Reserve Banks. Those
transactions must be governed with a
view to accommodating commerce and
business and with regard to their
bearing upon the general credit situation
of the country (12 U.S.C. 263). The
Board and the FOMC use the
information obtained from the FR 3036
to help fulfill these obligations.
The FR 3036 is a voluntary survey.
Because the release of this information
would cause substantial harm to the
competitive position of the entity from
whom the information was obtained, the
information collected on the FR 3036
may be granted confidential treatment
under exemption (b)(4) of the Freedom
of Information Act, (5 U.S.C. 552(b)(4)),
which protects from disclosure ‘‘trade
secrets and commercial or financial
information obtained from a person and
privileged or confidential.’’
Consultation outside the agency: This
survey is being coordinated by the BIS
with other participating central banks.
Board of Governors of the Federal Reserve
System, February 4, 2019.
Michele Taylor Fennell,
Assistant Secretary of the Board.
[FR Doc. 2019–01438 Filed 2–6–19; 8:45 am]
BILLING CODE 6210–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30-Day–19–0571]
Agency Forms Undergoing Paperwork
Reduction Act Review
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled Minimum Data
Elements (MDEs) for the National Breast
and Cervical Cancer Early Detection
Program (NBCCEDP) to the Office of
Management and Budget (OMB) for
review and approval. CDC previously
published a ‘‘Proposed Data Collection
Submitted for Public Comment and
Recommendations’’ notice on March 5,
2018 to obtain comments from the
public and affected agencies. CDC did
not receive comments related to the
previous notice. This notice serves to
VerDate Sep<11>2014
17:23 Feb 06, 2019
Jkt 247001
allow an additional 30 days for public
and affected agency comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570 or
send an email to omb@cdc.gov. Direct
written comments and/or suggestions
regarding the items contained in this
notice to the Attention: CDC Desk
Officer, Office of Management and
Budget, 725 17th Street NW,
Washington, DC 20503 or by fax to (202)
395–5806. Provide written comments
within 30 days of notice publication.
Proposed Project
Minimum Data Elements (MDEs) for
the National Breast and Cervical Cancer
Early Detection Program (NBCCEDP)—
(OMB No. 0920–0571, exp. 12/31/
2018)—Reinstatement with Change—
National Center for Chronic Disease
Prevention and Health Promotion
(NCCDPHP), Centers for Disease Control
and Prevention (CDC)
Background and Brief Description
CDC is requesting a Reinstatement
with Change to OMB No. 0920–0571.
Based on feedback from grantees and
internal subject matter experts, CDC
proposes use of revised minimum data
elements (MDEs).
PO 00000
Frm 00022
Fmt 4703
Sfmt 4703
Both breast and cervical cancers are
prevalent among U.S. women—in 2014,
more than 236,000 women were
diagnosed with breast cancer, and more
than 12,000 women were diagnosed
with cervical cancer. Evidence shows
that deaths from both breast and
cervical cancers can be avoided by
increasing screening services—
mammography and Pap tests—among
women. However, screening is typically
underutilized among women who are
under- or uninsured, have no regular
source of healthcare, or who recently
immigrated to the U.S.
Congress passed the Breast and
Cervical Cancer Mortality Prevention
Act of 1990, which directed CDC to
establish the National Breast and
Cervical Cancer Early Detection Program
(NBCCEDP). The purpose of the
NBCCEDP is to increase breast and
cervical cancer screening rates among
priority populations by funding grantees
to provide breast and cervical cancer
screening services to eligible women.
CDC issued a new funding opportunity
announcement to support a five-year
cooperative agreement under CDC–
RFA–DP17–1701. The number of
grantees will increase from 67 grantees
to 70 grantees.
CDC proposes a Reinstatement with
Change to the MDEs to include removal
of several data variables that are no
longer relevant for CDC analyses, as
well as collapsing/revising several data
variables to reduce burden and increase
clarity for respondents. The MDEs focus
on: (1) Patient demographics, (2) breast
cancer screening, (3) cervical cancer
screening, (4) breast and cervical cancer
diagnoses, (5) breast and cervical cancer
treatment, (6) timeliness of services, and
(7) patient navigation.
Redesigned data elements will enable
CDC to better gauge progress in meeting
clinical service delivery processes and
patient-level outcomes. Findings will
allow CDC to assess program progress in
meeting goals and monitor
implementation activities, evaluate
outcomes, and identify grantee technical
assistance needs. In addition, data
collected will inform program
improvement and help identify
successful activities that need to be
maintained, replicated, or expanded.
OMB approval is requested for three
years. The total estimated annualized
burden hours will decrease from 536 to
350 hours. There are no costs to
respondents other than their time.
E:\FR\FM\07FEN1.SGM
07FEN1
2509
Federal Register / Vol. 84, No. 26 / Thursday, February 7, 2019 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS
Type of respondents
Form name
NBCCEDP Grantees .......................................................................................
MDES ............
Jeffrey M. Zirger,
Acting Lead, Information Collection Review
Office, Office of Scientific Integrity, Office
of Science, Centers for Disease Control and
Prevention (CDC).
[FR Doc. 2019–01327 Filed 2–6–19; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30-Day–19–18JC]
Agency Forms Undergoing Paperwork
Reduction Act Review
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled ‘‘Women’s
Health Needs Study: The Health of U.S.Resident Women from Countries with
Prevalent Female Genital Mutilation/
Cutting (FGM/C)’’ to the Office of
Management and Budget (OMB) for
review and approval. CDC previously
published a ‘‘Proposed Data Collection
Submitted for Public Comment and
Recommendations’’ notice on March 20,
2018 to obtain comments from the
public and affected agencies. CDC
received three comments related to the
previous notice. This notice serves to
allow an additional 30 days for public
and affected agency comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
VerDate Sep<11>2014
17:23 Feb 06, 2019
Jkt 247001
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570 or
send an email to omb@cdc.gov. Direct
written comments and/or suggestions
regarding the items contained in this
notice to the Attention: CDC Desk
Officer, Office of Management and
Budget, 725 17th Street NW,
Washington, DC 20503 or by fax to (202)
395–5806. Provide written comments
within 30 days of notice publication.
Proposed Project
Women’s Health Needs Study: The
Health of U.S.-Resident Women from
Countries with Prevalent Female Genital
Mutilation/Cutting (FGM/C)—New—
National Center for Chronic Disease
Prevention and Health Promotion
(NCCDPHP), Centers for Disease Control
and Prevention (CDC).
Background and Brief Description
Female Genital Mutilation/Cutting
(FGM/C) is a practice common in many
countries; in parts of Asia, Africa and
the Middle East that can have severe,
deleterious health consequences for
women and girls. Recent studies suggest
that more than 500,000 women and girls
in the United States may have been cut
or be at risk for FGM/C based on
whether women or their mothers are
from countries with high prevalence of
FGM/C. However, this estimate was
derived using indirect techniques that
do not account for the differing
characteristics of women in the country
PO 00000
Frm 00023
Fmt 4703
Sfmt 4703
Number of
respondents
70
Number of
responses per
respondent
2
Average
burden per
response
(in hours)
150/60
of origin versus those who have
migrated to the United States, or any
other factors that are likely to affect the
prevalence of FGM/C. Additional major
knowledge gaps regarding FGM/C in the
United States include: The prevalence
of FGM/C in selected communities in
the United States with high
concentrations of residents from
countries where FGM/C is prevalent;
women’s attitudes about continuance of
the practice; and the health
characteristics and needs of women
living in the United States who have
experienced FGM/C or are at risk for
FGM/C.
This study aims to capture
information on women’s history of
FGM/C, their experiences with health
care services, and their attitudes about
continuation of the FGM/C practice.
Findings from this study will be used to
identify public health needs of women
and communities in the United States
that are affected by FGM/C, to formulate
public health strategies to meet
identified needs, and to inform
prevention efforts.
The proposed information collection
will include piloting and conducting a
full-scale survey of the health
experiences and needs of women who
live in selected communities in the
United States with high concentrations
of residents from countries where FGM/
C is widely practiced. The pilot study
will be conducted during the first year
of this project and will be used to assess
the feasibility of sampling and
recruiting methods for a hard-to-reach
population on a sensitive topic. Based
on findings from the pilot, a change
request, including necessary
translations, will be submitted to
conduct the full study during the
second and third year of this project.
The full study is planned to be
implemented in up to five community
sites in the United States. The estimated
annualized burden over the three years
of this project is 356 hours. There are no
costs to respondents other than their
time to participate.
E:\FR\FM\07FEN1.SGM
07FEN1
]]>Agencies
[Federal Register Volume 84, Number 26 (Thursday, February 7, 2019)]
[Notices]
[Pages 2508-2509]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-01327]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30-Day-19-0571]
Agency Forms Undergoing Paperwork Reduction Act Review
In accordance with the Paperwork Reduction Act of 1995, the Centers
for Disease Control and Prevention (CDC) has submitted the information
collection request titled Minimum Data Elements (MDEs) for the National
Breast and Cervical Cancer Early Detection Program (NBCCEDP) to the
Office of Management and Budget (OMB) for review and approval. CDC
previously published a ``Proposed Data Collection Submitted for Public
Comment and Recommendations'' notice on March 5, 2018 to obtain
comments from the public and affected agencies. CDC did not receive
comments related to the previous notice. This notice serves to allow an
additional 30 days for public and affected agency comments.
CDC will accept all comments for this proposed information
collection project. The Office of Management and Budget is particularly
interested in comments that:
(a) Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
(b) Evaluate the accuracy of the agencies estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and clarity of the information to
be collected;
(d) Minimize the burden of the collection of information on those
who are to respond, including, through the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology, e.g., permitting
electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570 or send an email to omb@cdc.gov. Direct written comments
and/or suggestions regarding the items contained in this notice to the
Attention: CDC Desk Officer, Office of Management and Budget, 725 17th
Street NW, Washington, DC 20503 or by fax to (202) 395-5806. Provide
written comments within 30 days of notice publication.
Proposed Project
Minimum Data Elements (MDEs) for the National Breast and Cervical
Cancer Early Detection Program (NBCCEDP)--(OMB No. 0920-0571, exp. 12/
31/2018)--Reinstatement with Change--National Center for Chronic
Disease Prevention and Health Promotion (NCCDPHP), Centers for Disease
Control and Prevention (CDC)
Background and Brief Description
CDC is requesting a Reinstatement with Change to OMB No. 0920-0571.
Based on feedback from grantees and internal subject matter experts,
CDC proposes use of revised minimum data elements (MDEs).
Both breast and cervical cancers are prevalent among U.S. women--in
2014, more than 236,000 women were diagnosed with breast cancer, and
more than 12,000 women were diagnosed with cervical cancer. Evidence
shows that deaths from both breast and cervical cancers can be avoided
by increasing screening services--mammography and Pap tests--among
women. However, screening is typically underutilized among women who
are under- or uninsured, have no regular source of healthcare, or who
recently immigrated to the U.S.
Congress passed the Breast and Cervical Cancer Mortality Prevention
Act of 1990, which directed CDC to establish the National Breast and
Cervical Cancer Early Detection Program (NBCCEDP). The purpose of the
NBCCEDP is to increase breast and cervical cancer screening rates among
priority populations by funding grantees to provide breast and cervical
cancer screening services to eligible women. CDC issued a new funding
opportunity announcement to support a five-year cooperative agreement
under CDC-RFA-DP17-1701. The number of grantees will increase from 67
grantees to 70 grantees.
CDC proposes a Reinstatement with Change to the MDEs to include
removal of several data variables that are no longer relevant for CDC
analyses, as well as collapsing/revising several data variables to
reduce burden and increase clarity for respondents. The MDEs focus on:
(1) Patient demographics, (2) breast cancer screening, (3) cervical
cancer screening, (4) breast and cervical cancer diagnoses, (5) breast
and cervical cancer treatment, (6) timeliness of services, and (7)
patient navigation.
Redesigned data elements will enable CDC to better gauge progress
in meeting clinical service delivery processes and patient-level
outcomes. Findings will allow CDC to assess program progress in meeting
goals and monitor implementation activities, evaluate outcomes, and
identify grantee technical assistance needs. In addition, data
collected will inform program improvement and help identify successful
activities that need to be maintained, replicated, or expanded.
OMB approval is requested for three years. The total estimated
annualized burden hours will decrease from 536 to 350 hours. There are
no costs to respondents other than their time.
[[Page 2509]]
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondents Form name Number of responses per per response
respondents respondent (in hours)
----------------------------------------------------------------------------------------------------------------
NBCCEDP Grantees.................... MDES...................... 70 2 150/60
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Acting Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention (CDC).
[FR Doc. 2019-01327 Filed 2-6-19; 8:45 am]
BILLING CODE 4163-18-P
